#$GSK is an active hashtag on Bluesky. In the last 30 days, 10 people shared 24 posts with it — around 1 a day. Activity is down 85% versus the previous week, peaking on Sep 15 with 8 posts.

Posts with #$GSK

おのたかし🍣

@onotakashi.highwill.jp

5 months ago

帯状疱疹ワクチン接種してきましたー！シングリックス（SHINGRIX）2回目です！ $GSK

2 0 67

おのたかし🍣

@onotakashi.highwill.jp

7 months ago

帯状疱疹ワクチン接種してきましたー！シングリックス（SHINGRIX）1回目です！ $GSK

おのたかし🍣 @onotakashi.highwill.jp

I am at 新浦安内科・脳神経内科クリニック and wanted you to know. Check out the details or leave a comment at: app.foursquare.com/share/checki...

app.foursquare.com

2 0 66

FirstWord Group

@firstwordgroup.com

1 day ago

European pharma's 'slow agony' of decline draws warning from nine industry chairs $AZN $GSK $IPN $NVO $NVS $RHHBY $SNY firstwordpharma.com/story…

0 0 0

Nicholas Brown

@nicholasabrown.bsky.social

25 days ago

".. more than $500 billion of projected global sales are at risk of losing patent protection by 2033, according to biopharma market-research company Norstella." @wsj.com $NVO $MRK $BMY $ABBV $AZN $GSK $PFE $SNY $JNJ $NVS $LLY www.wsj.com/health/pharm...

0 2 3

Librarian Capital

@librariancapital.bsky.social

3 months ago

This year is 20-year anniversary of controversy around $GSK marketing a drug* for "restless leg syndrome" This was widely ridiculed as a sign GSK had no pipeline Share performance since then has been mediocre *Ropinirole www.theguardian.com/scien….

0 0 2

midgardfinance.com

@midgardfinance.com

11 days ago

📊 #stocks 🇳🇱 $ASML took the most US institutional buying in Europe last quarter, +9.3% more shares held. 🇫🇷 Sanofi $SAN was cut hardest at -8.4%, then 🇬🇧 $GSK, 🇨🇭 $NOVN.

Horizontal bar chart of the change in shares of 25 European companies held by US institutional managers between 31 March and 30 June 2026, measured on their US listings. Bar length is the percentage change in share count, additions in blue to the right of zero and reductions in purple to the left. ASML +9.3 per cent, Unilever +4.6 per cent, NXP Semiconductors +3.2 per cent, Ferrari +3.1 per cent, Diageo +3.1 per cent, Deutsche Bank +3.0 per cent, Santander +2.8 per cent, AstraZeneca +2.2 per cent, Equinor +2.2 per cent, UBS +1.0 per cent, Rio Tinto +0.9 per cent, CRH +0.5 per cent, Spotify +0.5 per cent, Alcon +0.3 per cent, RELX +0.2 per cent, Shell +0.1 per cent, HSBC +0.1 per cent, TotalEnergies -0.0 per cent, Novo Nordisk -0.2 per cent, Vodafone -0.9 per cent, Barclays -2.9 per cent, SAP -2.9 per cent, Novartis -5.7 per cent, GSK -6.6 per cent, Sanofi -8.4 per cent. 17 of 25 were held in larger share counts at the end of June than at the end of March.

0 0 1

The Capitol Forum

@capitolforum.bsky.social

7 days ago

(2/2) CMS Can Better Screen for DME Fraud in Medicare Advantage, HHS-OIG Says library.thecapitolforum.c…. $AHCO $AMRX $CI $COR $CORT $CTEV $CVS $DFTX $GSK $HELP $HIMS $HUM $KR $LLY $MCK $RMD $SAN $SNY $TEVA $UNH $VTRS

0 0 0

BioPharmCatalyst

@biopharmcatalyst.bsky.social

7 days ago

🚨 October 2026 PDUFA Preview 🚨 👁️ $IRD – Presbyopia eye drop label expansion (10/17) 🧪 $GSK / $IONS – Priority Review for a functional Hepatitis B cure (10/26) 🧬 $INO – Surgery-sparing DNA medicine for rare respiratory tumors (10/30) www.biopharmcatalyst.com/…. #Biotech #PDUFA #stocks

0 0 0

@onlynexa.bsky.social

4 months ago

$GSK 52 CALL 5/22 @ .35

0 0 1

Catalyst Bulletin

@dealint.bsky.social

4 months ago

CB Daily Brief 09/06/26 $1912.HK: prospective mandatory offer by an investor at HK$0.365 $ZNC.AX: acquisition by $FRS.AX for 1/4.3x shares $RQI: rights issue $NUVL: acquisition by $GSK.L/$GSK for $124 $SGMO: strategic review

0 0 1

Catalyst Bulletin

@dealint.bsky.social

8 months ago

CB Daily Brief 20/01/26 $0751.HK: proposed spin-off of PV business & take-private at HK$4.03 $8031.HK: mandatory offer by an insider at HK$0.276 $KJELL.ST: rights issue $CPP.L: strategic review $RAPT: acquisition by $GSK.L/$GSK for $58 $ZDPY: asset sale & capital return

0 0 1